Arbitrum

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Enlivex (NASDAQ: ENLV) lists RAIN token on WhiteBIT to expand treasury liquidity across decentralized markets

Enlivex lists its RAIN token on WhiteBIT to expand liquidity and signal a bold digital treasury strategy. Find out what this means for biotech and crypto finance.

bySoujanya Ravi

January 26, 2026

Uniswap Labs launches v4 to enhance DeFi developer tools

Uniswap Labs has introduced Uniswap v4, the latest iteration of its decentralized finance (DeFi) protocol, bringing unprecedented flexibility…

byPallavi Madhiraju

February 2, 2025

The Latest

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Enlivex (NASDAQ: ENLV) lists RAIN token on WhiteBIT to expand treasury liquidity across decentralized markets

Uniswap Labs launches v4 to enhance DeFi developer tools

FDA Complete Response Letter puts Disc Medicine Inc.’s bitopertin timeline under pressure

What Humana Inc.’s MaxHealth acquisition signals for Medicare Advantage strategy

What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals

Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates

Vikran Engineering (NSE: VIKRAN) Q3 FY26 results show solar-led order book surge as margins reset during execution ramp-up

Ducon Infratechnologies (NSE: DUCON) Q3 FY26 results signal margin pressure even as carbon capture and AI bets move closer to execution

NATCO Pharma (NSE: NATCOPHARM) wins CDSCO approval for semaglutide as FDA compliance risks recede at its API unit

Zydus Lifesciences (NSE: Zyduslife) secures FDA approval for ammonium lactate cream as U.S. generics execution deepens